Abstract
This study examined the prevalence of and sociodemographic characteristics associated with elevated symptoms of depression among clients seeking alcohol or other drug (AOD) treatment. Consenting clients attending two AOD outpatient clinics answered demographics, treatment questions and the Patient Health Questionnaire to assess depressive symptoms. Counts and percentages were calculated to determine the prevalence of elevated depressive symptoms. Logistic regression was used to model the odds of having elevated depressive symptoms for client demographics. Of the 203 clients who completed the survey (87% consent rate), 55% (n = 111) demonstrated elevated depressive symptoms. Females were twice as likely to experience elevated symptoms of depression compared to males (OR 2.07; 95% CI 1.05, 4.08; P = 0.037). The high rates of elevated depressive symptoms among individuals seeking AOD treatment highlight the importance of ongoing research to provide effective treatments for this comorbidity. Routine screening and clear treatment pathways may assist with providing high quality care.
Similar content being viewed by others
References
Baker, A., Lee, N., Claire, M., Lewin, T., Grant, T., Pohlman, S., et al. (2004). Drug use patterns and mental health of regular amphetamine users during a reported ‘heroin drought’. Addiction,99(7), 875–884.
Berk, M., Hallam, K., Malhi, G., Henry, L., Hasty, M., Macneil, C., et al. (2010). Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health,19, 113–126.
Bilsker, D., & White, J. (2011). The silent epidemic of male suicide. BCMJ,53(10), 529–534.
Burgess, P., Pirkis, J., Slade, T., Johnston, A., Meadows, G., & Gunn, J. (2009). Service use for mental health problems: Findings from the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry,43, 615–623.
Burns, L., Teesson, M., & O’Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction,100(6), 787–796.
Chan, Y.-F., Dennis, M., & Funk, R. (2008). Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment,34(1), 14–24.
Cole, M., & Sacks, T. (2008). When dual diagnosis means no diagnosis: Co-occurring mental illness and problematic drug use in clients of alcohol and drug services in eastern metropolitan Melbourne. Mental Health and Substance Use,1, 33–43.
Darke, S., Swift, W., & Hall, W. (1994). Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction,89, 211–217.
Darke, S., Wodak, A., Hall, W., Heather, N., & Ward, J. (1992). Prevalence and predictors of psychopathology among opioid users. British Journal of Addiction,87, 771–776.
Davis, L., Frazier, E., Husain, M., Warden, D., Trivedi, M., Fava, M., et al. (2006). Substance use disorder comorbidity in major depressive disorder: A confirmatory analysis of the STAR*D cohort. Am J Addict,15, 278–285.
Deane, F., Kelly, P., Crowe, T., Coulson, J., & Lyons, G. (2013). Clinical and reliable change in an Australian residential substance use program using the addiction severity index. Journal of Addictive Diseases,32, 194–205.
Delgadillo, J., Payne, S., Gilbody, S., Godfrey, C., Gore, S., Jessop, D., et al. (2011). How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. Journal of Affective Disorders,134(1–3), 266–271.
Dingle, G., & King, P. (2009). Prevalence and impact of co-occurring psychiatric disorders on outcomes from a private hospital drug and alcohol treatment program. Mental Health and Substance Use,2, 13–23.
Dore, G., Mills, K., Murray, R., Teesson, M., & Farrugia, P. (2012). Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug and Alcohol Review,31, 294–301.
Dum, M., Pickren, J., Sobell, L., & Sobell, M. B. (2008). Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addictive Behaviors,33(2), 381–387.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., et al. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Medicine,10(11), e1001547.
Freeman, A., Tyrovolas, S., Koyanagi, A., Chatterji, S., Leonardi, M., Ayuso-Mateos, J., … Haro, J. (2016). The role of socio-economic status in depression: Results from the COURAGE (aging survey in Europe). BMC Public Health, 16, e1098.
Hepner, K. A., Hunter, S. B., Edelen, M. O., Zhou, A. J., & Watkins, K. (2009). A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. Journal of Substance Abuse Treatment,37(3), 318–325.
Hoebel, J., Maske, U., Zeeb, H., & Lampert, T. (2017). Social inequalities and depressive symptoms in adults: The role of objective and subjective socioeconomic status. PLoS ONE,12, e0169764.
Hood, S., & O’Neil, G. H. G. (2009). The role of flumazenil in the treatment of benzodiazepine dependence: Physiological and psychological profiles. Journal of Psychopharmacology,23, 401–409.
Jenkins, R. (2007). Substance use and suicidal behaviour. Psychiatry,6(1), 16–18.
Johns, K., Baker, A., Webster, R., & Lewin, T. (2009). Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems. Mental Health and Substance Use,2, 40–51.
Johnston, A., Pirkis, J., & Burgess, P. (2009). Suicidal thoughts and behaviours among Australian adults: Findings from the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry,43, 635–643.
Kingston, R. E. F., Marel, C., & Mills, K. (2016). A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia. Drug and Alcohol Review. https://doi.org/10.1111/dar.12448.
Kroenke, K., Spitzer, R., & Williams, J. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.
Lai, H. M., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence,154, 1–13.
Lejoyeux, M., & Lehert, P. (2011). Alcohol-use disorders and depression: Results from individual patient data meta-analysis of the acamprosate-controlled studies. Alcohol and Alcoholism,46(1), 61–67.
Lubman, D., Allen, N., Rogers, N., Cementon, E., & Bonomo, Y. (2007). The impact of co-occurring mood and anxiety disorders among substance-abusing youth. Journal of Affective Disorders,103, 105–112.
Marel, C., Mills, K., Kingston, R., Gournay, K., Deady, M., Kay-Lambkin, F., … Teesson, M. (2016). Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings. Retrieved from Sydney, Australia.
Martin, L., Neighbors, H., & Griffith, D. (2013). The experience of symptoms of depression in men vs women: Analysis of the National Comorbidity Survey Replication. JAMA Psychiatry,70(10), 1100–1106.
McKetin, R., Lubman, D., Lee, N., Ross, J., & Slade, T. (2011). Major depression among methamphetamine users entering drug treatment programs. Medical Journal of Australia,195, S51–S55.
Mortlock, K., Deane, F., & Crowe, T. (2011). Screening for mental disorder comorbidity in Australian alcohol and other drug residential treatment settings. Journal of Substance Abuse Treatment,40, 397–404.
Nunes, E., & Levin, F. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA,291(15), 1887–1896.
Riolo, S., Nguyen, T., Greden, J., & King, C. (2005). Prevalence of depression by race/ethnicity: Findings from the National Health and Nutrition Examination Survey III. American Journal of Public Health,95(6), 998–1000.
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., et al. (2005). The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review,24, 411–418.
Stafford, M., Jackson, H., Mayo-Wilson, E., Morrison, A., & Kendall, T. (2013). Early interventions to prevent psychosis: Systematic review and meta-analysis. BMJ,346, f185.
Staiger, P., Thomas, A., Ricciardelli, L., & McCabe, M. (2011). Identifying depression and anxiety disorders in people presenting for substance use treatment. Medical Journal of Australia,195, S60–S63.
Teesson, M., Slade, T., & Mills, K. (2009). Comorbidity in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry,43(7), 606–614.
Acknowledgements
This work was supported by a grant from the National Health and Medical Research Council (NHMRC) (1073031). Ms. Breanne Hobden is supported by an Australian Rotary Health, Ian Scott Mental Health PhD Scholarship (G1401254). Dr. Mariko Carey is supported by a National Health and Medical Research Council Translating Research into Practice Fellowship (1073031). Dr. Jamie Bryant is supported by an Australian Research Council Post-Doctoral Industry Fellowship (1105809). The researchers would like to thank the staff at the AOD clinics.
Author information
Authors and Affiliations
Contributions
All authors certify responsibility for this manuscript, as outlined by the Community Mental Health Journal.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare.
Ethical Approval
The Hunter New England Human Research Ethics Committee (15/06/17/4.02) and the University of Newcastle (H-2015-0414) granted full ethical approval for this research. All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hobden, B., Carey, M., Bryant, J. et al. Prevalence and Predictors of Symptoms of Depression Among Individuals Seeking Treatment from Australian Drug and Alcohol Outpatient Clinics. Community Ment Health J 56, 107–115 (2020). https://doi.org/10.1007/s10597-019-00451-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-019-00451-3